While they're not dominating headlines right now, tariffs are not over. Some key dates are coming up fast that could upend ...

Global markets exhibited mixed reactions as investors analyzed data on durable goods, employment, and consumer spending in ...

Calamos Market Neutral Income Strategy delivered on its aim of providing steady gains during the challenging quarter, ...

Despite the president hyping up a recent "deal" with China on tariffs, uncertainty has left consumers uneasy about the ...

The pharma industry has urged Bulgaria to reform drug pricing and clawbacks, warning current policies threaten patient access and foreign investment.